TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 5 | -1 | 25 | 69 | 47 | 24 | 28 |
| P | %wins | 67 | 67 | 100 | 100 | 100 | 100 | 89 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/22 16:05 | 3/3/22 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | P | 300 | 59.98 | 0 | 5 | 86 | 11 | D | |||||||||||||||
12/20/18 17:26 | 12/19/18 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Goldberg Mark Alan | PA | D | P | 32 | 3.19 | 0 | 10 | New | 10 | D | |||||||||||||||
11/7/18 09:54 | 11/6/18 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | P | 173 | 5.76 | 0 | 30 | 126 | 54 | D | |||||||||||||||
12/15/16 11:51 | 12/15/16 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | P | 36 | 1.80 | 2 | 20 | 526 | 24 | D | -81 | -86 | -49 | -36 | 8 | -12 | -11 | -3 | -5 | -12 | 44 | 101 | |||
3/7/16 08:03 | 3/4/16 | GLYC | Glycomimetics Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MD | D | P | 50 | 4.77 | 0 | 10 | 945 | 11 | D | -65 | -37 | -26 | -25 | 3 | 32 | 4 | 15 | 18 | 9 | 18 | 73 | 43 | 24 | |
11/9/12 11:06 | 11/8/12 | IMGN | Immunogen Inc | MA | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MA | D | P | 34 | 11.27 | 8 | 3 | 375 | 4 | D | 39 | -16 | -14 | -13 | -30 | -28 | -3 | -3 | 1 | 0 | 12 | 32 | 50 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |